Health Care Services

SOFTMEDX

SOFTMEDX released FY2025 9 Months Earnings on March 27, 2026 (BJT) with actual revenue of HKD 52.01 M and EPS of HKD 0.249

SOFTMEDX released FY2025 Q3 earnings on March 27, 2026 (BJT), with actual revenue of HKD 16.24 M and EPS of HKD 0.0021

SOFTMEDX released FY2025 Annual Earnings on March 27 During-Market (BJT), actual revenue HKD 68.24 M, actual EPS HKD 0.2406

SOFTMEDX released FY2025 Q4 earnings on March 27 During-Market (BJT), actual revenue HKD 16.24 M, actual EPS HKD 0.0433

SOFTMEDX to Release FY2025 Earnings on March 27 During-Market BJT

SOFTMEDX released FY2025 Q1 earnings on August 18, 2025 (BJT) with actual revenue of HKD 17.89 M and EPS of HKD 0.1028

SOFTMEDX released FY2024 Semi-Annual Earnings on August 18, 2025 (BJT) with actual revenue of HKD 30.7 M and EPS of HKD -0.0186

SOFTMEDX released FY2025 Q2 earnings on August 18, 2025 (BJT) with actual revenue of HKD 17.89 M and EPS of HKD 0.1028

SOFTMEDX released FY2025 Semi-Annual Earnings on August 18, 2025 (BJT), with actual revenue of HKD 35.77 M and EPS of HKD 0.2056

SOFTMEDX released FY2024 Q2 earnings on August 18, 2025 (BJT), actual revenue HKD 15.35 M, actual EPS HKD -0.1868

SOFTMEDX released FY2024 Q1 earnings on August 18, 2025 (BJT) with actual revenue of HKD 15.35 M and EPS of HKD -0.1868

SOFTMEDX released FY2024 Q3 earnings on April 28, 2025 (BJT), actual revenue HKD 11.97 M, actual EPS HKD 10.1954

SOFTMEDX released FY2023 Q3 earnings on April 28 (BJT), actual revenue HKD 15.37 M, actual EPS HKD 0.5025

SOFTMEDX released FY2024 Q4 earnings on April 28, 2025 (BJT), with actual revenue of HKD 11.97 M and EPS of HKD 10.1954

SOFTMEDX released FY2023 Q4 earnings on April 28, 2025 (BJT), actual revenue HKD 15.37 M, actual EPS HKD 0.0251

SOFTMEDX released FY2024 9-month earnings on April 28, 2025 (BJT), with actual revenue of HKD 42.67 M and EPS of HKD 9.8217

SOFTMEDX released FY2023 Annual Earnings on April 28, 2025 (BJT), actual revenue HKD 51.34 M, actual EPS HKD 0.7674

SOFTMEDX released FY2024 Annual Earnings on April 28, 2025 (BJT), with actual revenue of HKD 54.64 M and EPS of HKD 20.0171

Jingjiu Health announces 2024 annual performance with revenue of HKD 54.639 million, up 6.43%

Hong Kong SFC Initiates Legal Proceedings Against Former Directors of Kingsoft Medical

HINSANG GROUP

RIVERINE CHINA

PASHUN INT RTS

BRAINAURORA-B

GOLDENPOWER

ZHONGKE GROUP

VISION SYNERGY

GEMILANG INTL

GHPC

00648

SOFTMEDX announced a proposed share consolidation of 20 for 1. After the consolidation takes effect, the trading unit will change from 5,000 shares to 1,000 shares. The share consolidation is expected to take effect on May 19 (Tuesday)

AASTOCKS

SOFTMEDX recommends a 20-for-1 stock split, changing each lot to 1,000 shares for trading

SoftMedx Healthcare Limited has avoided a HK$412 million fair value loss for the year ending December 31, 2025, which was not recognized in its financial statements. The company reported a net profit of HK$10 million from ordinary operations and an overall net profit of HK$7 million for 2025. This announcement alleviates previous investor concerns following a profit warning. SoftMedx advises shareholders to review its full annual results and exercise caution in trading its shares. The company is part of China Wah Yan Healthcare and operates in the healthcare sector.

Tip Ranks

SoftMedx Avoids HK$412 Million Fair Value Loss and Posts 2025 Profit

08082

02706

In the past hour, the Hong Kong stock market has shown a clear divergence, with significant fluctuations in individual stocks mainly concentrated in the healthcare and technology sectors. The strong rise of SOFTMEDX has attracted considerable capital inflow, while QINGHUA HOLD and HAIZHI TECH GP have faced substantial selling pressure, reflecting the volatility of market sentiment. Short-term enthusiasm seems to lean towards technology stocks with growth potential, as funds quickly switch between these stocks, creating a more active trading atmosphere. The stock with the largest movement in the past hour, SOFTMEDX, surged 22.88%, with significant capital inflow under the strong market attention, driving the stock price up rapidly and indicating investors' optimistic expectations for its future development. Meanwhile, XUNCE also performed well, with a rise of 19.36%, as short-term sentiment soared, attracting a large amount of short-term capital. Strong stocks include: 1. REDCO HEALTHY: up 16.87%, as demand for its health products has surged recently, pushing the stock price higher. 2. YOFC: up 15.05%, with the advancement of 5G construction, the market is full of expectations for its prospects, and capital inflow is evident. 3. BIREN TECH: up 13.83%, with short-term funds actively entering against the backdrop of technological innovation, driving the stock price up. 4. BEST LINKING: up 13.33%, the company's recent earnings forecast has sparked market discussions, attracting considerable buying interest. 5. INNOSCIENCE: up 12.58%, with the industry recovery, the market holds an optimistic view of its future development

HK Stock Alerts

QINGHUA HOLD

HAIZHI TECH GP

XUNCE

STARCOIN GROUP

REDCO HEALTHY

YOFC

BIREN TECH

BEST LINKING

INNOSCIENCE

BWI INT'L

AE LOGISTICS

TONGGUAN GOLD

GUANZE MEDICAL

Hong Kong Stock Movement Update: Medical stocks rebound strongly, SOFTMEDX surges 22.88%! QINGHUA HOLD falls by 20%

02110

List of companies resuming trading today (Resumption time - 9:00 AM) Stock Code Stock Name 00648 SOFTMEDX 02110 TIAN CHENG HLDG 08532 Pao Fa Holdings

etnet

TIAN CHENG HLDG

"Memo on Resumption of Trading" List of Listed Companies Resuming Trading Today

SoftMedx Healthcare Limited has resumed trading after meeting all Stock Exchange resumption guidance requirements. The company published outstanding financial results with unqualified auditor opinions, ensuring compliance with listing rules. This development enhances its market position and reassures shareholders about its financial health. SoftMedx, part of China Wah Yan Healthcare Group, focuses on distributing medical equipment and products in Hong Kong, generating revenue through sales and supportive services. Current market cap stands at HK$123.9M.

SoftMedx Healthcare Resumes Trading After Meeting Stock Exchange Requirements

According to the Zhitong Finance APP, SOFTMEDX announced that the company is pleased to inform its shareholders and potential investors that as of the date of this announcement, the company has met the resumption guidelines. The Securities and Futures Commission has notified the Stock Exchange that, in accordance with Section 9(3) of the Securities Rules, the company's shares trading on the original counter (code: 648) and the temporary counter (code: 2906) will be allowed to resume at 9:00 AM on November 4, 2025

Zhitong

On November 4th, SOFTMEDX will resume trading

SoftMedx Healthcare Limited has resumed trading on the Stock Exchange of Hong Kong after addressing regulatory concerns that led to a suspension in November 2017. The resumption is subject to the company meeting specific conditions, including publishing announcements and undergoing a follow-up review by an independent consultant. The initial suspension was due to issues related to a transaction with New Ray Medicine International Holding Limited, raising questions about the management's integrity.

SoftMedx Healthcare Resumes Trading After Addressing Regulatory Concerns

SOFTMEDX(00648.HK)